Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
Mahler MR, Magyari M, Pontieri L, Elberling F, Holm RP, Weglewski A, Poulsen MB, Storr LK, Bekyarov PA, Illes Z, Kant M, Sejbaek T, Stilund ML, Rasmussen PV, Brask M, Urbonaviciute I, Sellebjerg F.
Mahler MR, et al. Among authors: brask m.
J Neurol Neurosurg Psychiatry. 2024 Sep 17;95(10):979-987. doi: 10.1136/jnnp-2023-333265.
J Neurol Neurosurg Psychiatry. 2024.
PMID: 38569873